Clinical Trial Update: Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) [Phase 2]

View source ↗

Summary

Completed Phase 2 pharmacokinetic study of caspofungin in neonates and infants to evaluate dosing in candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis

Drugs mentioned

• Caspofungin (Cancidas) (caspofungin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Candidiasis | Phase 2 | Status: COMPLETED